Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Fiomi Diagnostics AB
Mandate

Vinge advises on the sale of Fiomi Diagnostics AB

March 05, 2012

Vinge has advised the shareholders of Fiomi Diagnostics AB in connection with the sale of the shares in the company to Trinity Biotech plc, which is quoted on NASDAQ. Fiomi, which is based in Uppsala, develops platforms for point-of-care diagnostics based on a technology which originated from Uppsala Åmice AB.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Claes Henriksson and Louise Markgren as well as project assistants Ida Norlin

Related

Vinge has advised Gamma Waves on Sportway’s EUR 20 million financing round

 Vinge has acted as legal adviser to Gamma Waves in connection with Sportway’s EUR 20 million financing round. The round was led by Gamma Waves, together with continued participation from existing shareholders, and values Sportway at approximately EUR 92 million (around SEK 1 billion) post-money.
June 24, 2026

Vinge advises Spotlight Group in connection with offer from Kriptown

 Vinge is advising Spotlight Group AB (publ) in connection with Kriptown SAS having made a public cash takeover offer to the shareholders of Spotlight Group
June 17, 2026

Vinge has advised EQT IX in connection with its exit of Beijer Ref AB (publ)

 Vinge has advised EQT IX (”EQT”) in connection with the sale of all of its remaining shares of series B in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 15 June 2026.
June 16, 2026